GATC Biotech and LifeCodexx Develop a Diagnostic Test for Early Detection of Preeclampsia

Project is funded with 500,000 Euros from the BMBF

16-May-2011 - Germany

On the basis of next generation sequencing technologies GATC Biotech and LifeCodexx will develop a human genetic diagnostic test that will allow the detection of cell-free fetal DNA as an important early marker for preeclampsia. The test would allow a reliable risk assessment before symptoms appear. The project is supported by grants from the KMU Innovation Program of the Federal Ministry for Research and Education with 500,000 Euros over the next two years.

"Currently there is no reliable method to predict preeclampsia. This new genetic test will therefore provide additional assurance early in pregnancy," said Dr. Wera Hofmann, Medical Director of LifeCodexx AG.

"We will immediately investigate the new PacBio RS technology for use in the test protocol. This sequencing system of the Third Generation can analyze single molecules in real-time within minutes. Costs and duration of the diagnostic test could be drastically reduced,” added Peter Pohl, CEO of GATC Biotech and chairman of LifeCodexx.

“We are pleased to have a second diagnostic test in our development pipeline, in addition to the non-invasive prenatal diagnostic test for the determination of trisomy 21. It is another step forward towards our goal to become a leader in the field of Next Generation Molecular Diagnostics,” said Dr. Michael Lutz, CEO of LifeCodexx AG.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures